Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional)

Organization
DHHS - NIH
Type
DHHS
Application Due Date
09-14-2023
Number
NOT-CA-23-066
Brief Description

The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to the Advancing Cancer Control Equity Research through Transformative Solutions (ACCERT) initiative. Up to four (4) Research Centers and one (1) Coordination Center will be funded as part of the ACCERT Consortium's effort to address the impact of social determinants of health (SDOH) on adverse cancer control outcomes. Each Research Center will: 1) develop interventions that target the multilevel pathways by which SDOH impact adverse cancer outcomes; 2) develop measures, methods, and assess community-level SDOH, community engagement and cancer control equity processes and outcomes; and 3) build capacity among diverse scholars and community partners to implement interventions that incorporate the lived experiences of those who face cancer inequities. The NOFO will utilize the U19 Research Program - Cooperative Agreements activity code. The NOFO is expected to be published in Summer 2023 with an expected application due date in early Fall 2023. Details of a pre-application webinar will be announced after the publication of the NOFO. The NOFO is expected to use the U19 mechanism; clinical trial is optional. This Notice is being provided to allow potential applicants with meaningful community collaborations time to develop responsive projects, and with relevant expertise and insights to consider applying for this new NOFO. Potential applicants are encouraged to view the presentation of this initiative to the Joint Virtual Meeting of the NCI Board of Scientific Advisors (BSA) and the National Cancer Advisory Board (NCAB), available at: (https://videocast.nih.gov/watch=48653) beginning at 1 hour, 8 minutes. Presentation slides are downloadable at: https://deainfo.nci.nih.gov/advisory/joint/1222/Oh.pdf.